Equities Analysts Offer Predictions for FULC FY2026 Earnings
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Fulcrum Therapeutics in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska expects that the company will post earnings per share of ($1.04) for the year. Cantor Fitzgerald […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Fulcrum Therapeutics in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska expects that the company will post earnings per share of ($1.04) for the year. Cantor Fitzgerald […]
